These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 15850403

  • 1. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M, Liu G, Pinon DI, Miller LJ.
    Biochemistry; 2005 May 03; 44(17):6693-700. PubMed ID: 15850403
    [Abstract] [Full Text] [Related]

  • 2. Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformations.
    Dong M, Hadac EM, Pinon DI, Miller LJ.
    Mol Pharmacol; 2005 Jun 03; 67(6):1892-900. PubMed ID: 15774770
    [Abstract] [Full Text] [Related]

  • 3. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
    Hadac EM, Ji Z, Pinon DI, Henne RM, Lybrand TP, Miller LJ.
    J Med Chem; 1999 Jun 17; 42(12):2105-11. PubMed ID: 10377216
    [Abstract] [Full Text] [Related]

  • 4. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M.
    Biochemistry; 1998 Nov 24; 37(47):16494-505. PubMed ID: 9843416
    [Abstract] [Full Text] [Related]

  • 5. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
    Arlander SJ, Dong M, Ding XQ, Pinon DI, Miller LJ.
    Mol Pharmacol; 2004 Sep 24; 66(3):545-52. PubMed ID: 15322246
    [Abstract] [Full Text] [Related]

  • 6. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 24; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 7. Demonstration of a specific site of covalent labeling of the human motilin receptor using a biologically active photolabile motilin analog.
    Matsuura B, Dong M, Coulie B, Pinon DI, Miller LJ.
    J Pharmacol Exp Ther; 2005 Jun 24; 313(3):1101-8. PubMed ID: 15677347
    [Abstract] [Full Text] [Related]

  • 8. Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP.
    Dejda A, Bourgault S, Doan ND, Létourneau M, Couvineau A, Vaudry H, Vaudry D, Fournier A.
    Biochimie; 2011 Apr 24; 93(4):669-77. PubMed ID: 21185349
    [Abstract] [Full Text] [Related]

  • 9. Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling.
    Dong M, Miller LJ.
    Peptides; 2013 Aug 24; 46():143-9. PubMed ID: 23770253
    [Abstract] [Full Text] [Related]

  • 10. Direct identification of the agonist binding site in the human brain cholecystokininB receptor.
    Anders J, Blüggel M, Meyer HE, Kühne R, ter Laak AM, Kojro E, Fahrenholz F.
    Biochemistry; 1999 May 11; 38(19):6043-55. PubMed ID: 10320330
    [Abstract] [Full Text] [Related]

  • 11. Molecular approximation between residue 10 of secretin and its receptor demonstrated by photoaffinity labeling.
    Dong M, Miller LJ.
    Ann N Y Acad Sci; 2006 Jul 11; 1070():243-7. PubMed ID: 16888174
    [Abstract] [Full Text] [Related]

  • 12. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor.
    Kasheverov IE, Chiara DC, Zhmak MN, Maslennikov IV, Pashkov VS, Arseniev AS, Utkin YN, Cohen JB, Tsetlin VI.
    FEBS J; 2006 Apr 11; 273(7):1373-88. PubMed ID: 16689926
    [Abstract] [Full Text] [Related]

  • 13. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM, Mills JS, Gripentrog JM, Dratz EA, Granger BL, Jesaitis AJ.
    J Immunol; 1997 Oct 15; 159(8):4045-54. PubMed ID: 9378994
    [Abstract] [Full Text] [Related]

  • 14. Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.
    Dong M, Lam PC, Gao F, Hosohata K, Pinon DI, Sexton PM, Abagyan R, Miller LJ.
    Mol Pharmacol; 2007 Aug 15; 72(2):280-90. PubMed ID: 17475809
    [Abstract] [Full Text] [Related]

  • 15. Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor.
    Hadac EM, Dawson ES, Darrow JW, Sugg EE, Lybrand TP, Miller LJ.
    J Med Chem; 2006 Feb 09; 49(3):850-63. PubMed ID: 16451051
    [Abstract] [Full Text] [Related]

  • 16. Differential spatial approximation between secretin and its receptor residues in active and inactive conformations demonstrated by photoaffinity labeling.
    Dong M, Hosohata K, Pinon DI, Muthukumaraswamy N, Miller LJ.
    Mol Endocrinol; 2006 Jul 09; 20(7):1688-98. PubMed ID: 16513792
    [Abstract] [Full Text] [Related]

  • 17. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
    Harikumar KG, Pinon DI, Wessels WS, Dawson ES, Lybrand TP, Prendergast FG, Miller LJ.
    Mol Pharmacol; 2004 Jan 09; 65(1):28-35. PubMed ID: 14722234
    [Abstract] [Full Text] [Related]

  • 18. Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe.
    Ding XQ, Dolu V, Hadac EM, Holicky EL, Pinon DI, Lybrand TP, Miller LJ.
    J Biol Chem; 2001 Feb 09; 276(6):4236-44. PubMed ID: 11050076
    [Abstract] [Full Text] [Related]

  • 19. Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model.
    Jossart C, Coupal M, McNicoll N, Fournier A, Wilkes BC, De Léan A.
    Biochemistry; 2005 Feb 22; 44(7):2397-408. PubMed ID: 15709752
    [Abstract] [Full Text] [Related]

  • 20. Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor.
    Dong M, Wang Y, Hadac EM, Pinon DI, Holicky E, Miller LJ.
    J Biol Chem; 1999 Jul 02; 274(27):19161-7. PubMed ID: 10383421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.